Skip to content
Trial Agents

Stefanini

Stefanini is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
4recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

A Phase 3, randomized, open-label study of belantamab mafodotin administered in combination with lenalidomide and dexamethasone versus daratumumab, lenalidomide, and dexamethasone in participants with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (TI-NDMM)-DREAMM-10

Sponsor Glaxosmithkline Research & Development Limited

Start (EU)
Latest update
Estimated end

A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease

Sponsor Argenx

Start (EU)
Latest update
Estimated end

A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease

Sponsor Argenx

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Stefanini?

The 2026-10-09 snapshot links Stefanini to 5 distinct CTIS trials. Recorded services include Digital Cameras Provision, Digital health services, Electronic data capture, Technical support level 1 for Banook Group. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Stefanini?

The most frequently recorded therapeutic areas are Immunology, Endocrinology, Ophthalmology, Gastroenterology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Stefanini conducted?

The linked trials record locations in 19 countries, including Spain, Italy, Bulgaria, Czechia, Germany. These are trial locations, not confirmed office locations or countries where Stefanini delivered services.

What can this page tell me about Stefanini's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Stefanini. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Stefanini

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.